TABLE A2.
The relative abundances of 24 pathways were significantly changed in DROE compared with NROE
| Pathway |
NROE relative frequency (%) mean ± SD |
DROE relative frequency (%) mean ± SD |
p‐values |
|---|---|---|---|
| PWY‐7090 | 0.0015 ± 0.0016 | 0.0020 ± 0.0029 | 0.0052 |
| PWY‐7332 | 0.0084 ± 0.0138 | 0.0120 ± 0.0192 | 0.0077 |
| PWY‐5484 | 0.6120 ± 0.1064 | 0.6382 ± 0.1169 | 0.0077 |
| GLYCOLYSIS | 0.7214 ± 0.0761 | 0.7392 ± 0.0873 | 0.0121 |
| PWY‐841 | 0.5670 ± 0.0867 | 0.5853 ± 0.0904 | 0.0201 |
| PWY‐7228 | 0.4474 ± 0.0969 | 0.4669 ± 0.1017 | 0.0274 |
| DENOVOPURINE2‐PWY | 0.5743 ± 0.0830 | 0.5907 ± 0.0835 | 0.0289 |
| P108‐PWY | 0.4183 ± 0.1360 | 0.4460 ± 0.1627 | 0.0305 |
| PWY‐6125 | 0.4791 ± 0.0936 | 0.4972 ± 0.0959 | 0.0335 |
| PWY‐7184 | 0.3343 ± 0.0715 | 0.3481 ± 0.0773 | 0.0351 |
| GLUCUROCAT‐PWY | 0.2332 ± 0.0724 | 0.2194 ± 0.0764 | 0.0367 |
| PWY‐6519 | 0.2480 ± 0.1223 | 0.2251 ± 0.1235 | 0.0379 |
| PWY‐6353 | 0.2724 ± 0.0803 | 0.2575 ± 0.0765 | 0.0380 |
| PWY‐4984 | 0.0908 ± 0.0592 | 0.1024 ± 0.0713 | 0.0381 |
| PENTOSE‐P‐PWY | 0.3659 ± 0.1145 | 0.3875 ± 0.1281 | 0.0415 |
| PWY‐7197 | 0.3461 ± 0.0930 | 0.3633 ± 0.0969 | 0.0423 |
| PWY‐7200 | 0.3666 ± 0.0601 | 0.3776 ± 0.0599 | 0.0433 |
| PWY‐5505 | 0.5909 ± 0.1517 | 0.5628 ± 0.1648 | 0.0437 |
| GALACT‐GLUCUROCAT‐PWY | 0.2503 ± 0.0707 | 0.2374 ± 0.0741 | 0.0441 |
| PWY0‐162 | 0.5776 ± 0.0972 | 0.5953 ± 0.0975 | 0.0448 |
| PWY0‐166 | 0.4008 ± 0.0591 | 0.4118 ± 0.0667 | 0.0456 |
| P125‐PWY | 0.0074 ± 0.0160 | 0.0112 ± 0.0365 | 0.0471 |
| PWY0‐1296 | 0.4674 ± 0.1002 | 0.4492 ± 0.1098 | 0.0483 |
| PWY‐7196 | 0.5194 ± 0.1089 | 0.5388 ± 0.1110 | 0.0491 |